Dr. Palit
ActiveSummary
Dr. Palit has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €837,102 and a net result of €123,294. Equity is growing by ~20.5% per year across the filed fiscal years. Its solvency ranks better than 72% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability84▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €70,000 at 30 days acceptable
Liquidity ample (current ratio 12.72 against 10.15 in 2024; short-term debt: 5.8% and cash: 3.2% of total assets), and 17.9% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
82.1%
Return on assets
12.1%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
4 d early
2024
1 d early
2023
on the day
2021
4 d early
2020
1 d late
2019
25 d early
2018
28 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 1 day before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 30 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close01-10-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#7 company by equity in Wijnegem, Health and social work sector#8 company by total assets in Wijnegem, Health and social work sector
Equity
€837,102▲ 17.3%
2024 · €713,808
Total assets
€1.0m▲ 10.4%
2024 · €923,148
Net result
€123,294▲ 2.3%
2024 · €120,546
Working capital
€692,041▲ 17.8%
2024 · €587,351
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202320242025
Operating result€132,075▲ 19.4%€161,663▲ 22.4%€161,839-€173,258▲ 7.1%€157,541▼ 9.1%
Net result€99,803above the sector's middle half▲ 45.0%€112,326above the sector's middle half▲ 12.5%€132,443above the sector's middle half-€120,546above the sector's middle half▼ 9.0%€123,294within the sector's middle half▲ 2.3%
Equity€308,244within the sector's middle half▲ 47.9%€420,570above the sector's middle half▲ 36.4%€593,263above the sector's middle half-€713,808above the sector's middle half▲ 20.3%€837,102above the sector's middle half▲ 17.3%
Total assets€603,789within the sector's middle half▲ 54.9%€683,633above the sector's middle half▲ 13.2%€802,551above the sector's middle half-€923,148above the sector's middle half▲ 15.0%€1.0mabove the sector's middle half▲ 10.4%
Debt€295,545▲ 62.9%€263,063▼ 11.0%€209,288-€209,340=€182,112▼ 13.0%
Working capital€232,195within the sector's middle half▲ 33.9%€336,245above the sector's middle half▲ 44.8%€484,342above the sector's middle half-€587,351above the sector's middle half▲ 21.3%€692,041above the sector's middle half▲ 17.8%
Solvency51.1%within the sector's middle half▼ 2.4pp61.5%within the sector's middle half▲ 10.5pp73.9%within the sector's middle half-77.3%within the sector's middle half▲ 3.4pp82.1%within the sector's middle half▲ 4.8pp
Current ratio4.54within the sector's middle half▲ 0.657.22above the sector's middle half▲ 2.6712.39above the sector's middle half-10.15above the sector's middle half▼ 2.2512.72above the sector's middle half▲ 2.58
Return on assets (ROA)16.5%within the sector's middle half▼ 1.1pp16.4%within the sector's middle half▼ 0.1pp16.5%within the sector's middle half-13.1%within the sector's middle half▼ 3.4pp12.1%within the sector's middle half▼ 1.0pp
Staff (FTE)1-1=1=
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 9% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.0m
Fixed assets
€268,141 ▼ 1.3%
Current assets
€751,074 ▲ 15.3%
Equity and liabilities €1.0m
Equity
€837,102 ▲ 17.3%
Debt
€182,112 ▼ 13.0%
Debt's share of the balance-sheet total falls from 22.7% to 17.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€172,566▼
2024 · €188,387
Cash flow
€138,319▲
2024 · €135,674
Debt to equity
0.22▼
2024 · 0.29
ROE
14.7%▼
2024 · 16.9%
Interest coverage
33.59▲
2024 · 31.70
Debt ≤ 1 year
€59,032▼
2024 · €64,222
Debt > 1 year
€123,080▼
2024 · €145,118
Income taxes
€59,081▼
2024 · €67,972
Staff costs
€13,811▲
2024 · €13,311
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,696 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.7%
went bankrupt
3.9%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,696 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €196 | €17,500 | - | - |
| Remuneration, social security and pensions62 | - | - | €13,924 | €13,311 | €13,811 | ▲ 3.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €16,703 | €17,191 | €16,807 | €15,129 | €15,025 | ▼ 0.7% |
| Other operating charges640/8 | - | - | €1,394 | €1,388 | €2,556 | ▲ 84.1% |
| Gross operating margin9900 | €155,112 | €185,825 | €193,964 | €203,087 | €188,933 | ▼ 7.0% |
| Operating profit (loss)9901 | €132,075 | €161,663 | €161,839 | €173,258 | €157,541 | ▼ 9.1% |
| Financial income75/76B | - | - | €18,077 | €21,202 | €29,970 | ▲ 41.4% |
| Recurring financial income75 | €20,578 | €8,440 | €18,077 | €21,202 | €29,970 | ▲ 41.4% |
| Financial charges65/66B | - | - | €4,559 | €5,942 | €5,137 | ▼ 13.5% |
| Recurring financial charges65 | €7,719 | €6,188 | €4,559 | €5,942 | €5,137 | ▼ 13.5% |
| Profit (loss) for the period before taxes9903 | €144,934 | €163,915 | €175,357 | €188,518 | €182,374 | ▼ 3.3% |
| Income taxes67/77 | €45,131 | €51,589 | €42,914 | €67,972 | €59,081 | ▼ 13.1% |
| Profit (loss) for the period9904 | €99,803 | €112,326 | €132,443 | €120,546 | €123,294 | ▲ 2.3% |
| Profit (loss) for the period to be appropriated9905 | €99,803 | €112,326 | €132,443 | €120,546 | €123,294 | ▲ 2.3% |
| Line | 2020 | 2021 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €603,789 | €683,633 | €802,551 | €923,148 | €1.0m | ▲ 10.4% |
| Fixed assets21/28 | €306,081 | €293,287 | €275,694 | €271,575 | €268,141 | ▼ 1.3% |
| Tangible fixed assets22/27 | €301,081 | €288,287 | €270,694 | €266,575 | €263,141 | ▼ 1.3% |
| Land and buildings22 | - | - | €259,425 | €262,939 | €248,953 | ▼ 5.3% |
| Plant, machinery and equipment23 | - | - | €2,477 | €1,824 | €1,463 | ▼ 19.8% |
| Furniture and vehicles24 | - | - | €8,792 | €1,812 | €7,874 | ▲ 335% |
| Other tangible fixed assets26 | - | - | - | - | €4,850 | - |
| Financial fixed assets28 | €5,000 | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Current assets29/58 | €297,708 | €390,346 | €526,857 | €651,573 | €751,074 | ▲ 15.3% |
| Amounts receivable after more than one year29 | - | - | €270,000 | €270,000 | €270,000 | = |
| Trade receivables290 | - | - | €270,000 | €270,000 | €270,000 | = |
| Amounts receivable within one year40/41 | €272,901 | €59,372 | €225,026 | €319,645 | €433,328 | ▲ 35.6% |
| Trade receivables40 | - | - | €205 | €4,867 | - | - |
| Other amounts receivable41 | - | - | €224,821 | €314,778 | €433,328 | ▲ 37.7% |
| Cash at bank and in hand54/58 | €24,226 | €53,698 | €31,831 | €61,929 | €32,963 | ▼ 46.8% |
| Deferred charges and accrued income490/1 | - | - | - | - | €14,782 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €603,789 | €683,633 | €802,551 | €923,148 | €1.0m | ▲ 10.4% |
| Equity10/15 | €308,244 | €420,570 | €593,263 | €713,808 | €837,102 | ▲ 17.3% |
| Contributions10/11 | €12,400 | - | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €186,554 | €298,880 | €298,880 | €419,426 | €542,719 | ▲ 29.4% |
| Non-distributable reserves130/1 | - | - | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | - | €1,860 | €1,860 | €1,860 | = |
| Tax-exempt reserves132 | - | - | €246 | €246 | €246 | = |
| Distributable reserves133 | - | - | €296,774 | €417,320 | €540,613 | ▲ 29.5% |
| Profit (loss) carried forward14 | €109,290 | €109,290 | €281,983 | €281,983 | €281,983 | = |
| Amounts payable17/49 | €295,545 | €263,063 | €209,288 | €209,340 | €182,112 | ▼ 13.0% |
| Amounts payable after more than one year17 | €230,032 | €208,962 | €166,773 | €145,118 | €123,080 | ▼ 15.2% |
| Financial debts170/4 | - | - | €166,773 | €145,118 | €123,080 | ▼ 15.2% |
| Amounts payable within one year42/48 | €65,513 | €54,101 | €42,516 | €64,222 | €59,032 | ▼ 8.1% |
| Current portion of amounts payable after more than one year42 | - | - | €21,279 | €21,655 | €22,038 | ▲ 1.8% |
| Financial debts43 | - | - | €11,189 | €11,667 | €11,667 | = |
| Credit institutions430/8 | - | - | €11,189 | €11,667 | €11,667 | = |
| Trade debts44 | €19,432 | €1,705 | €17 | €7,350 | €3,244 | ▼ 55.9% |
| Suppliers440/4 | - | - | €17 | €7,350 | €3,244 | ▼ 55.9% |
| Taxes, remuneration and social security45 | - | - | €10,030 | €23,550 | €22,084 | ▼ 6.2% |
| Taxes450/3 | - | - | €7,914 | €19,699 | €19,575 | ▼ 0.6% |
| Remuneration and social security454/9 | - | - | €2,116 | €3,851 | €2,509 | ▼ 34.9% |
| Line | 2020 | 2021 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €99,803 | €112,326 | €132,443 | €120,546 | €123,294 | ▲ 2.3% |
| + Depreciation and write-downs630 | €16,703 | €17,191 | €16,807 | €15,129 | €15,025 | ▼ 0.7% |
| Operating cash flow (approximation) | €116,506 | €129,517 | €149,250 | €135,674 | €138,319 | ▲ 1.9% |
| Investment in fixed assets (approximation) | - | -€4,398 | - | -€11,010 | -€11,591 | ▼ 5.3% |
| Change in cash | - | €29,471 | - | €30,097 | -€28,966 | ▼ 196% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Highest result since 2019net €132,443 ▲17.9%
Net result €132,443, the highest in the series.
30-06
Financial
Equity above €500,000Eq €593,263 ▲41.1%
4 profitable years in a row build equity to €593,263.
2022
27-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
01-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 1 day late
2020
06-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
28-02
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 28 days late
2018
08-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 36 days late
2017
03-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
2016
10-02
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Wijnegem · 1 establishment unit since 2009
Ground area
681 m²
Building footprint
183 m²
Volume, LiDAR
1,063 m³
Parcel 11050B0291/00V003, Flanders · tallest building 8.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Palit
since 20092.179.963.548
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11050B0291/00V003 | Flanders | 681 m² | 1 · 183 m² | 8.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 30-06-2025 list no shareholders, and no other source names one.
Holdings 1
-
25%
According to the annual accounts to 30-06-2025 of Dr. Palit and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
DR. FRANK PROVENIER CARDIOLOOG
BE 0466.557.033
Maldegem · Eq €837,021
SOCIETE DE MEDECINE KADOU JOE
BE 0838.591.922
Wezembeek-Oppem · Eq €836,976
DR SOENEN A
BE 0795.742.765
Ieper · Eq €836,831
Medisoma
BE 0888.868.012
Schilde · Eq €836,094
GOCARDIO
BE 0877.661.839
Saint-Ghislain · Eq €838,155
Of 16,625 companies in this sector we hold annual accounts for 7,989. 5,979 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company (pre-2019)
Founded29-07-2009
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0817426126
Registered
02-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.